Allakos Inc expected to post a loss of 29 cents a share - Earnings Preview
U.S. STOCKS ON THE MOVE-M-tron, Rocket Companies, TKO Group
Allakos soars on buyout deal with Concentra Biosciences
Brief: Allakos Inc. Enters Into Agreement To Be Acquired By Concentra Biosciences
Allakos Inc reports results for the quarter ended December 31 - Earnings Summary
Brief: Allakos Q4 Net Income USD 376 Thousand
Allakos Inc expected to post a loss of 17 cents a share - Earnings Preview
U.S. STOCKS ON THE MOVE-Middleby, Boeing, Aurora Mobile
U.S. STOCKS ON THE MOVE-Sagimet Biosciences, Sage Therapeutics, Qorvo
U.S. STOCKS ON THE MOVE-Tevogen Bio, Akero Therapeutics, AspenTech
Allakos falls over 70% after halting development of skin condition drug
Allakos Inc expected to post a loss of 21 cents a share - Earnings Preview
Brief: Allakos Q3 Net Income USD -18.372 Million
Brief: Allakos Announces Phase 1 Trial Results Of Subcutaneous Ak006 In Healthy Volunteers
U.S. RESEARCH ROUNDUP-Amphastar Pharmaceuticals, Guardant Health, Upwork
Allakos Inc reports results for the quarter ended in June - Earnings Summary
Brief: Allakos Q2 Net Income USD -26.676 Million
Allakos Inc expected to post a loss of 33 cents a share - Earnings Preview
Brief: Allakos Says AK006 Well-Tolerated In Ongoing Phase 1 Trial